Published in Mol Genet Genomic Med on July 06, 2017
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 97.51
SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res (2003) 52.26
MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods (2010) 16.61
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90
Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet (2011) 14.29
Improved splice site detection in Genie. J Comput Biol (1997) 11.57
PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics (2005) 9.88
Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol (1991) 7.93
dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum Mutat (2011) 6.97
The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet (2014) 6.69
PTC124 targets genetic disorders caused by nonsense mutations. Nature (2007) 6.67
Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet (2013) 6.67
Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res (1996) 6.13
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet (2005) 4.98
Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat Genet (2000) 4.81
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Res (2006) 4.00
A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet (2000) 2.87
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science (1998) 2.84
Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. Am J Hum Genet (2000) 2.66
Next-generation genetic testing for retinitis pigmentosa. Hum Mutat (2012) 2.30
PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleles are responsible for both USH1F and DFNB23. Hum Mol Genet (2003) 2.14
A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat (2013) 2.07
Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. Am J Hum Genet (2004) 1.88
Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet (2001) 1.87
Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies. Eur J Hum Genet (2013) 1.83
Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76
Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%. J Med Genet (2006) 1.72
Disease boundaries in the retina of patients with Usher syndrome caused by MYO7A gene mutations. Invest Ophthalmol Vis Sci (2008) 1.69
Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian families. Eur J Hum Genet (2009) 1.67
Development of a genotyping microarray for Usher syndrome. J Med Genet (2006) 1.63
Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children. Genet Med (2010) 1.56
Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study. J Med Genet (2011) 1.54
Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. Hum Mutat (2008) 1.53
Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa. Exp Eye Res (2004) 1.51
Molecular and in silico analyses of the full-length isoform of usherin identify new pathogenic alleles in Usher type II patients. Hum Mutat (2007) 1.48
Enrichment of LOVD-USHbases with 152 USH2A genotypes defines an extensive mutational spectrum and highlights missense hotspots. Hum Mutat (2014) 1.45
Identification of novel USH2A mutations: implications for the structure of USH2A protein. Eur J Hum Genet (2000) 1.45
Genotype-phenotype correlation and mutation spectrum in a large cohort of patients with inherited retinal dystrophy revealed by next-generation sequencing. Genet Med (2014) 1.44
A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. Am J Hum Genet (1999) 1.42
Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One (2013) 1.40
Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction. Hum Mutat (2007) 1.38
Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy. Hum Mutat (2011) 1.36
Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. J Med Genet (2010) 1.35
Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. Invest Ophthalmol Vis Sci (2009) 1.33
Evaluation of the myosin VIIA gene and visual function in patients with Usher syndrome type I. Exp Eye Res (2000) 1.31
Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene. Invest Ophthalmol Vis Sci (2008) 1.31
Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II. J Med Genet (2006) 1.27
Mutation spectrum of MYO7A and evaluation of a novel nonsyndromic deafness DFNB2 allele with residual function. Hum Mutat (2008) 1.27
Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins. Am J Hum Genet (1997) 1.26
Identification and in vitro expression of novel CDH23 mutations of patients with Usher syndrome type 1D. Hum Mutat (2002) 1.25
Genes associated with retinitis pigmentosa and allied diseases are frequently mutated in the general population. PLoS One (2012) 1.23
Genetics: advances in genetic testing for deafness. Curr Opin Pediatr (2012) 1.23
Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis (2013) 1.22
Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I: confirmation of genetic heterogeneity. Hum Mutat (1999) 1.22
Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families. Hum Mutat (2000) 1.15
USH2A mutation analysis in 70 Dutch families with Usher syndrome type II. Hum Mutat (2004) 1.13
Diverse spectrum of rare deafness genes underlies early-childhood hearing loss in Japanese patients: a cross-sectional, multi-center next-generation sequencing study. Orphanet J Rare Dis (2013) 1.12
Next-generation sequencing-based molecular diagnosis of 82 retinitis pigmentosa probands from Northern Ireland. Hum Genet (2014) 1.10
Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations. Orphanet J Rare Dis (2011) 1.09
A novel D458V mutation in the SANS PDZ binding motif causes atypical Usher syndrome. J Mol Med (Berl) (2005) 1.07
MYO7A mutation screening in Usher syndrome type I patients from diverse origins. J Med Genet (2007) 1.05
Infantile hyperinsulinism associated with enteropathy, deafness and renal tubulopathy: clinical manifestations of a syndrome caused by a contiguous gene deletion located on chromosome 11p. J Pediatr Endocrinol Metab (2004) 1.04
Targeted and genomewide NGS data disqualify mutations in MYO1A, the "DFNA48 gene", as a cause of deafness. Hum Mutat (2014) 1.04
Identification of large rearrangements of the PCDH15 gene by combined MLPA and a CGH: large duplications are responsible for Usher syndrome. Invest Ophthalmol Vis Sci (2010) 1.02
Ex vivo splicing assays of mutations at noncanonical positions of splice sites in USHER genes. Hum Mutat (2010) 1.01
High-throughput retina-array for screening 93 genes involved in inherited retinal dystrophy. Invest Ophthalmol Vis Sci (2011) 1.01
A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation. EMBO Mol Med (2012) 1.00
Spectrum of mutations in USH2A in British patients with Usher syndrome type II. Exp Eye Res (2001) 0.98
A domain-specific usherin/collagen IV interaction may be required for stable integration into the basement membrane superstructure. J Cell Sci (2004) 0.98
Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2. Arch Ophthalmol (2007) 0.98
Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II. J Hum Genet (2009) 0.96
Dependable and efficient clinical utility of target capture-based deep sequencing in molecular diagnosis of retinitis pigmentosa. Invest Ophthalmol Vis Sci (2014) 0.95
Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews. Genet Test (2008) 0.95
Experience of targeted Usher exome sequencing as a clinical test. Mol Genet Genomic Med (2013) 0.94
Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum Genet (2016) 0.93
A comprehensive analysis of sequence variants and putative disease-causing mutations in photoreceptor-specific nuclear receptor NR2E3. Mol Vis (2009) 0.92
Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. Am J Hum Genet (2003) 0.91
Heimler Syndrome Is Caused by Hypomorphic Mutations in the Peroxisome-Biogenesis Genes PEX1 and PEX6. Am J Hum Genet (2015) 0.90
Retinal disease course in Usher syndrome 1B due to MYO7A mutations. Invest Ophthalmol Vis Sci (2011) 0.90
Whole exome analysis identifies frequent CNGA1 mutations in Japanese population with autosomal recessive retinitis pigmentosa. PLoS One (2014) 0.90
Targeted next generation sequencing for molecular diagnosis of Usher syndrome. Orphanet J Rare Dis (2014) 0.88
Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome. Mol Genet Genomic Med (2014) 0.88
Expanding the clinical, allelic, and locus heterogeneity of retinal dystrophies. Genet Med (2015) 0.88
The USH2A c.2299delG mutation: dating its common origin in a Southern European population. Eur J Hum Genet (2010) 0.87
Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy. Surv Ophthalmol (2010) 0.86
Whole USH2A Gene Sequencing Identifies Several New Deep Intronic Mutations. Hum Mutat (2015) 0.86
NGS-based Molecular diagnosis of 105 eyeGENE(®) probands with Retinitis Pigmentosa. Sci Rep (2015) 0.84
Targeted exon sequencing in Usher syndrome type I. Invest Ophthalmol Vis Sci (2014) 0.84
Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood. J Inherit Metab Dis (2015) 0.83
A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants. Eur J Hum Genet (2015) 0.83
Sensorineural hearing loss, enamel hypoplasia, and nail abnormalities in sibs. Am J Med Genet (1991) 0.83
An Usher syndrome type 1 patient diagnosed before the appearance of visual symptoms by MYO7A mutation analysis. Int J Pediatr Otorhinolaryngol (2012) 0.82
The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease. J Neurol Neurosurg Psychiatry (2010) 0.82
A novel 5-bp deletion in Clarin 1 in a family with Usher syndrome. Ophthalmic Genet (2011) 0.81
Emerging therapies for inherited retinal degeneration. Sci Transl Med (2016) 0.80
When One Diagnosis Is Not Enough. N Engl J Med (2016) 0.80
Comprehensive molecular diagnosis of 67 Chinese Usher syndrome probands: high rate of ethnicity specific mutations in Chinese USH patients. Orphanet J Rare Dis (2015) 0.79
An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients. Eur J Hum Genet (2016) 0.79